RecruitingNCT00177268

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research


Sponsor

University of Pittsburgh

Enrollment

200 participants

Start Date

Oct 1, 2004

Study Type

OBSERVATIONAL

Conditions

Summary

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects blood, urine, and tissue samples from people with cutaneous T-cell lymphoma (CTCL) — a type of skin cancer — as well as those with eczema or atopic dermatitis, to help researchers find better treatments. **You may be eligible if...** - You are 18 years of age or older - You have been diagnosed with cutaneous T-cell lymphoma (CTCL) - You have been diagnosed with atopic dermatitis or eczema **You may NOT be eligible if...** - You do not have a confirmed medical record diagnosis of CTCL, atopic dermatitis, or eczema Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood draw, skin biopsy or urine collection

Up to 9 blood draws/year of 60 ml of whole blood. One 6 mm punch biopsy may be obtained up to 4 times per year.


Locations(1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00177268


Related Trials